Corporate Responsiblity - Ascendis Pharma US

Home About Us Corporate Responsiblity

We are a biopharmaceutical company with high ethical standards, and we take responsibility for our actions

At Ascendis Pharma, we are 100 percent committed to making a difference for patients around the globe, and doing so with high ethical standards.

We work in fair, honest and respectful cooperation with potential customers and external business partners, which may include individuals, suppliers, consultants, distributors, agents, intermediaries, public and private clinics, hospitals, universities and institutions, as well as non-governmental organizations. We take responsibility for our actions. We do not compromise our commitment to integrity or our values.

Our Code of Business Conduct & Ethics provides general guidance regarding how to conduct business in a compliant way.

Code of Conduct

Our Code of Business Conduct & Ethics translates our values into consistent action by addressing, assisting and resolving ethical decisions and compliance matters that may arise in our day-to-day work. The Code of Business Conduct & Ethics sets out general guidelines on how to conduct business in a consistent way in accordance with high global standards on business ethics.

Download the Code of Business Conduct & Ethics

English

German

Learn more about our Code of Business Conduct & Ethics

This guidance may be supported by more specific company policies and guidelines. In addition, we have mechanisms to address and resolve ethical issues and compliance concerns that may arise at any point in our day-to-day work.

The Code of Business Conduct & Ethics applies to all Ascendis Pharma employees, Senior Management, Board Members as well as any third parties, who, due to certain roles and responsibilities, are likewise made fully subject to this Code of Business Conduct & Ethics and specific policies.

At Ascendis Pharma, we work in fair, honest and respectful cooperation with potential customers and external business partners, which may include individuals or legal entities with whom we work in partnership, i.e. suppliers, consultants, distributors, agents, intermediaries, public and private clinics, hospitals, universities and institutions, as well as non-governmental organizations. We seek to partner with competent contract research organizations (CROs), contract manufacturing organizations (CMOs) and other third parties to support our deliverables. We expect that our external business partners comply with the principles of the Ascendis Pharma Code of Business Conduct & Ethics.

We work in fair, honest and respectful cooperation with others.

Whistleblower Hotline

If you are aware of any known or suspected violation of the Code of Business Conduct & Ethics, including violations of the laws, rules, regulations or company policies, you may use our Whistleblower Hotline.

Our Whistleblower Hotline is available 24 hours a day, 7 days a week

Access Hotline

Learn more about our Whistleblower Policy

Complaints are handled by Group Compliance, and the Chairman of the Audit Committee is notified about any reported complaints. The procedures for investigation of the individual complaint will depend on the nature and significance of the complaint.

Ascendis Pharma has adopted a reporting procedure, including a non-retaliation policy, which sets forth the standards and procedures for reporting questionable conduct and addresses confidentiality concerns and protection for persons reporting questionable behavior. When you report a suspected wrongdoing in good faith, based upon your reasonable belief, and you are not engaged in associated improper conduct, Ascendis Pharma will keep your identity confidential to the extent possible. In order to thoroughly investigate a complaint, however, Ascendis Pharma may find it necessary to share information with others on a “need to know” basis.

While efforts will be made to maintain the confidentiality of your identity, the existence and particulars of the complaint itself may have to be disclosed to the individual(s) about whom the complaint is made. In each instance, the investigation team will determine the appropriateness of bringing the disclosure to the attention of management, to the individual(s) against whom the complaint is made and to the Audit Committee or the Board of Directors.